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Objective: Hypothermic circulatory arrest is widely used for adults with aortic arch dis-
ease as well as for children with congenital heart disease. At present, no method exists
for monitoring safe duration of circulatory arrest. Near-infrared spectroscopy is a new
technique for noninvasive monitoring of cerebral oxygenation and energy state. In the
current study, the relationship between near-infrared spectroscopy data and neurologic
outcome was evaluated in a survival piglet model with hypothermic circulatory arrest.
Methods: Thirty-six piglets (9.36 ± 0.16 kg) underwent circulatory arrest under
varying conditions with continuous monitoring by near-infrared spectroscopy (tem-
perature 15°C or 25°C, hematocrit value 20% or 30%, circulatory arrest time 60, 80,
or 100 minutes). Each setting included 3 animals. Neurologic recovery was evalu-
ated daily by neurologic deficit score and overall performance category. Brain was
fixed in situ on postoperative day 4 and examined by histologic score. 
Results: Oxygenated hemoglobin signal declined to a plateau (nadir) during circu-
latory arrest. Time to nadir was significantly shorter with lower hematocrit value (P
< .001) and higher temperature (P < .01). Duration from reaching nadir until reper-
fusion (“oxygenated hemoglobin signal nadir time”) was significantly related to
histologic score (rs = 0.826), neurologic deficit score (rs = 0.717 on postoperative
day 1; 0.716 on postoperative day 4), and overall performance category (rs = 0.642
on postoperative day 1; 0.702 on postoperative day 4) (P < .001). All animals in
which oxygenated hemoglobin signal nadir time was less than 25 minutes were free
of behavioral or histologic evidence of brain injury.
Conclusion: Oxygenated hemoglobin signal nadir time determined by near-infrared
spectroscopy monitoring is a useful predictor of safe duration of circulatory arrest.
Safe duration of hypothermic circulatory arrest is strongly influenced by perfusate
hematocrit value and temperature during circulatory arrest.
The technique of hypothermic circulatory arrest (HCA) continues tobe widely used both for acquired cardiovascular disease (archaneurysm repair, pulmonary embolectomy) and for congenital heartdisease. Although many studies have made it clear that neurologicand developmental impairment can follow use of HCA in somepatients under some conditions,1,2 the technique continues to be
applied with no method for monitoring safe duration. Presently available methods
of monitoring, for example, electroencephalography or jugular venous saturation,
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are unreliable or irrelevant under conditions of deep
hypothermia, hemodilution, pH shifts, and circulatory
arrest.3,4 Furthermore, widely different protocols are used to
achieve HCA with considerable ongoing controversy
regarding optimal pH strategy (pH-stat versus alpha-stat),
optimal hematocrit value, and optimal temperature and flow
conditions before HCA (cooling rate and duration).
Near-infrared spectroscopy (NIRS) is a relatively new tech-
nique for assessment of cerebral oxygenation.5-7 Although
serious questions remain regarding the validity of the
cytochrome signal measured by NIRS,8,8a the information
regarding hemoglobin oxygenation has been well validated.
The aim of the present study was to determine a safe
duration of HCA as assessed by neurologic and histologic
examination in a survival piglet model with HCA and to
study the influence of hematocrit value and temperature on
safe duration. All animals were monitored with NIRS with
a view to deriving a NIRS parameter that was predictive of
safe duration of HCA.
Material and Method
Experimental Preparation
Details of the surgical instrumentation in the survival piglet model
have been described elsewhere.9 Thirty-eight 5- or 6-week-old
Yorkshire piglets, weighing 9.36 ± 0.16 kg, were sedated with intra-
muscular ketamine (20 mg/kg) and xylazine (4 mg/kg) and intubated
with 5-mm cuffed endotracheal tubes. Each animal was ventilated at
a peak inspiratory pressure of 20 cm H2O, an inspired oxygen frac-
tion of 0.21, and a rate of 12 to 15 breaths/min by means of a pres-
sure-controlled ventilator (Healthdyne model 105; Healthdyne
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TABLE I.  Experimental conditions 1
Variable Group 1 Group 2 Group 3 Group 4 ANOVA (P)
Body weight (kg)
Before operation 9.00 ± 0.36 9.25 ± 0.28 9.51 ± 0.37 9.68 ± 0.26 .47
POD 1 9.73 ± 0.37 10.60 ± 0.21 10.15 ± 0.36 11.48 ± 0.27 .0027*
% 108.2 ± 0.8 114.9 ± 1.2 106.9 ± 0.6 118.7 ± 1.7 <.0001*
POD 4 8.84 ± 0.35 9.21 ± 0.30 9.81 ± 0.41 9.88 ± 0.40 .19
% 101.0 ± 2.20 99.5 ± 1.0 103.4 ± 2.6 101.5 ± 1.7 .58
Hematocrit (%)
Before CPB 27.3 ± 0.5 28.8 ± 1.4 26.3 ± 0.6 27.0 ± 0.7 .27
CPB prime 32.2 ± 0.9 13.0 ± 0.4 32.0 ± 0.9 13.2 ± 0.4 <.0001*
On CPB 33.2 ± 0.6 20.3 ± 0.6 33.2 ± 0.7 20.2 ± 0.7 <.0001*
Cooling 10 min 33.6 ± 0.6 21.9 ± 0.4 32.8 ± 0.7 21.3 ± 0.4 <.0001*
30 min 33.6 ± 0.8 20.7 ± 0.3 33.1 ± 0.8 21.2 ± 0.5 <.0001*
Rewarming 10 min 32.6 ± 0.7 23.2 ± 0.6 33.3 ± 1.0 25.9 ± 1.6 <.0001*
30 min 34.4 ± 0.7 27.4 ± 0.7 34.2 ± 0.7 29.4 ± 0.9 <.0001*
30 min off CPB 29.2 ± 1.0 26.6 ± 0.8 28.4 ± 0.5 26.1 ± 1.0 .04
POD 1 32.0 ± 0.9 29.2 ± 0.9 30.1 ± 0.8 29.4 ± 0.4 .06
Temperature (°C)
Before CPB 37.31 ± 0.24 36.99 ± 0.36 37.46 ± 0.22 37.43 ± 0.21 .58
On CPB 37.54 ± 0.20 37.09 ± 0.42 37.57 ± 0.08 37.51 ± 0.14 .48
End of cooling 13.33 ± 0.13 13.39 ± 0.14 22.94 ± 0.08 22.92 ± 0.07 <.0001*
End of HCA 15.73 ± 0.36 16.62 ± 0.39 24.87 ± 0.26 25.40 ± 0.19 <.0001*
Rewarming 40 min 37.32 ± 0.19 37.28 ± 0.22 37.72 ± 0.11 37.79 ± 0.14 .09
3 h 36.42 ± 0.40 36.62 ± 0.37 37.10 ± 0.33 36.58 ± 0.32 .57
POD 1 37.27 ± 0.17 37.50 ± 0.14 37.43 ± 0.12 37.46 ± 0.18 .72
Mean arterial pressure (mm Hg)
Before CPB 88.8 ± 5.4 87.3 ± 4.1 86.2 ± 4.8 97.9 ± 4.8 .28
On CPB 91.6 ± 5.1 62.1 ± 7.8 85.6 ± 5.7 52.8 ± 7.0 .0005*
Cooling 10 min 69.1 ± 5.2 52.9 ± 5.3 94.2 ± 4.7 61.8 ± 5.5 <.0001*
30 min 56.9 ± 5.7 46.8 ± 3.7 88.6 ± 6.5 63.9 ± 5.0 <.0001*
Rewarming 10 min 51.1 ± 6.3 43.8 ± 4.9 65.8 ± 3.9 67.5 ± 4.6 .0055*
30 min 93.0 ± 7.1 101.4 ± 5.5 104.7 ± 9.1 92.4 ± 7.6 .58
30 min off CPB 81.8 ± 3.9 80.3 ± 3.3 74.3 ± 3.1 78.9 ± 6.2 .64
3 h 97.9 ± 4.2 95.9 ± 4.3 86.3 ± 6.3 97.2 ± 4.3 .32
POD 1 91.0 ± 3.7 95.9 ± 5.0 99.7 ± 3.6 99.2 ± 4.9 .48
CPB, Cardiopulmonary bypass; POD, postoperative day.
*P < .0083 is statistically significant by analysis of variance and Bonferroni.
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Technologies, Marietta, Ga) to achieve a normal pH and PaCO2. A
pair of fiberoptic optodes for NIRS was placed on the head over the
frontal lobes, with an interoptode distance of 4.0 cm. The total body
water content was estimated by bioelectrical impedance with the use
of a Weight Manager Analyzer (BIA-101Q; RJL Systems, Inc,
Clinton Township, Mich). After an intravenous bolus injection of fen-
tanyl (50 µg/kg) and pancuronium (0.5 mg/kg), anesthesia was main-
tained by a continuous infusion of fentanyl (25 µg · kg–1 · h–1), mida-
zolam (0.2 mg · kg–1 · h–1) and pancuronium (0.2 mg · kg–1 · h–1)
throughout the entire experiment, except during the period of HCA.
All surgical procedures were performed under sterile condi-
tions. For intraoperative monitoring and blood sampling, arteri-
al and venous lines were placed in the left superficial femoral
artery and right femoral vein, respectively. The right femoral
artery was exposed for the cardiopulmonary bypass (CPB) arte-
rial cannula, and a right anterolateral thoracotomy was per-
formed in the third intercostal space to expose the right atrium
for venous cannulation. After systemic heparinization (300
IU/kg), an 8F arterial cannula (Medtronic BioMedicus, Eden
Prairie, Minn) and a 28F venous cannula (Research Medical,
Inc, Midvale, Utah) were inserted into the right femoral artery
and right atrial appendage, respectively.
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the
Figure 1. Results of NIRS. DPF, Differential path-length factor; HCA, hypothermic circulatory arrest; Gp, group.
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National Society for Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996.
Experimental Groups
Hematocrit value. During the cooling phase a hematocrit value
of either 20% or 30% was maintained.
Duration of HCA. A circulatory arrest time of 60, 80, or 100
minutes was used.
Temperature during HCA. An esophageal temperature of
either 15°C or 25°C was used.
The experimental design included these three parameters with
two or three possible values resulting in 2 × 3 × 2 = 12 experi-
mental settings. Each setting was performed in 3 piglets. In the
group with a hematocrit value of 20%, the CPB prime consisted of
400 mL of blood and 800 mL of crystalloid solution. The other
group (hematocrit value of 30%) was prepared with 1200 mL of
whole-blood prime.
For ease of description, animals were considered in one of four
groups with different hematocrit values and temperatures (group 1:
hematocrit value 30%, temperature 15°C; group 2: 20%, 15°C;
group 3: 30%, 25°C; and group 4: 20%, 25°C) with three different
durations of circulatory arrest (60, 80, or 100 minutes) in each
group. Operative conditions and intraoperative data including
NIRS data were evaluated between the groups, and the relationship
Cardiopulmonary Support and Physiology Sakamoto et al
TABLE II. Experimental conditions 2
Variable Group 1 Group 2 Group 3 Group 4 ANOVA (P)
Percent total body water
Off CPB 98.3 ± 1.6 114.6 ± 3.7 98.9 ± 1.4 113.4 ± 2.5 <.0001*
1 h 110.8 ± 2.7 126.3 ± 3.2 111.8 ± 2.1 129.4 ± 2.8 .0003*
3 h 118.7 ± 3.1 140.9 ± 3.6 118.5 ± 2.2 142.0 ± 3.2 <.0001*
POD 1 123.9 ± 3.6 148.8 ± 3.0 127.2 ± 2.6 152.4 ± 4.6 <.0001*
Osmolarity (Osm)
Before CPB 270.6 ± 1.3 272.7 ± 1.8 270.9 ± 1.2 270.7 ± 1.3 .69
On CPB 278.1 ± 1.0 273.7 ± 1.0 275.3 ± 1.4 270.8 ± 1.3 .0010*
Cooling 30 min 282.1 ± 1.3 275.9 ± 0.9 280.4 ± 1.2 275.9 ± 1.0 .0003*
Rewarming 30 min 280.3 ± 1.5 277.8 ± 1.0 280.0 ± 1.8 278.7 ± 1.2 .55
30 min of CPB 279.6 ± 1.6 278.9 ± 1.3 278.8 ± 1.6 278.9 ± 1.3 .97
POD 1 278.8 ± 1.9 279.6 ± 1.3 279.7 ± 1.3 280.8 ± 1.6 .85
SvO2 (%)
On CPB 77.23 ± 1.43 57.47 ± 2.33 73.81 ± 2.07 50.34 ± 4.01 <.0001*
Cooling 10 min 90.76 ± 0.70 83.22 ± 2.76 83.97 ± 1.65 69.26 ± 2.33 <.0001*
20 min 97.61 ± 0.51 95.22 ± 0.91 91.01 ± 0.93 83.84 ± 1.46 <.0001*
30 min 99.69 ± 0.08 99.38 ± 0.20 94.28 ± 0.73 90.08 ± 1.04 <.0001*
Rewarming 10 min 94.45 ± 0.54 93.90 ± 1.15 92.74 ± 0.41 91.26 ± 1.13 .08
20 min 91.20 ± 1.01 87.23 ± 1.23 88.73 ± 0.94 88.28 ± 1.31 .13
30 min 85.86 ± 1.52 83.31 ± 1.80 85.90 ± 0.79 81.02 ± 2.81 .23
pH†
Before CPB 7.484 ± 0.015 7.501 ± 0.014 7.482 ± 0.016 7.493 ± 0.022 .86
Cooling 30 min 7.441 ± 0.017 7.411 ± 0.007 7.451 ± 0.013 7.411 ± 0.012 .07
Rewarming 30 min 7.388 ± 0.014 7.409 ± 0.012 7.350 ± 0.012 7.332 ± 0.014 .0006*
3 h 7.490 ± 0.013 7.489 ± 0.010 7.450 ± 0.017 7.441 ± 0.011 .02
PaCO2 (mm Hg)†
Before CPB 39.20 ± 1.62 39.56 ± 2.55 39.29 ± 2.09 38.93 ± 1.64 .99
Cooling 30 min 44.16 ± 2.06 41.36 ± 1.87 46.10 ± 1.32 43.44 ± 1.02 .25
Rewarming 30 min 44.28 ± 1.48 41.86 ± 1.10 46.83 ± 1.67 45.96 ± 1.87 .14
3 h 41.12 ± 1.72 40.80 ± 1.72 43.36 ± 1.61 43.66 ± 1.76 .53
PaO2 (mm Hg)†
Before CPB 91.66 ± 4.74 92.17 ± 5.21 93.07 ± 4.15 88.17 ± 4.37 .89
Cooling 30 min 636.28 ± 20.62 628.34 ± 16.28 577.47 ± 12.49 567.93 ± 18.72 .02
Rewarming 30 min 479.91 ± 11.31 478.14 ± 8.99 480.49 ± 10.81 485.86 ± 15.89 .97
3 h 486.84 ± 37.20 483.91 ± 14.28 463.22 ± 10.33 437.43 ± 23.03 .43
SvO2, Mixed venous saturation; CPB, cardiopulmonary bypass; POD, postoperative day.
*P < .0083 is statistically significant by analysis of variance and Bonferroni.
†pH, PaCO2, and PaO2 are corrected for temperature.
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between NIRS data and the neurologic outcome was examined
comprehensively.
CPB Technique
The CPB circuit consisted of a roller pump, membrane oxygenator
(Minimax; Medtronic), and sterile tubing, with a 40-µm arterial fil-
ter (Olson Medical Sales, Inc, Ashland, Mass). The prime was
determined by the experimental protocol. Methylprednisolone (30
mg/kg), furosemide (0.25 mg/kg), sodium bicarbonate (10 mL),
cefazolin sodium (25 mg/kg), fentanyl (50 µg/kg), and pancuroni-
um (0.5 mg/kg) were added to the prime. Full bypass flow was set
at 100 mL · kg–1 · min–1, and pH-stat management was selected.
CPB was started and the animals were perfused for 10 minutes at
normothermia (37°C). Animals were then cooled to an esophageal
temperature of 13°C to 14°C or 23°C to 24°C over 40 minutes
according to the experimental protocol. Ventilation was stopped
after the establishment of CPB. Each group underwent 60, 80, or
100 minutes of HCA at 14°C to 15°C or 24°C to 25°C, according
to the experimental protocol. Before reperfusion, methylpred-
nisolone (30 mg/kg), furosemide (0.25 mg/kg), sodium bicarbon-
ate (10 mL), and mannitol (0.5 g/kg) were administered into the
pump. Reperfusion was begun at a rate of 100 mL kg–1 · min–1, and
each animal was warmed to 37°C. The heart was defibrillated as
necessary at an esophageal temperature of 30°C. Fresh whole
blood from a donor pig, drawn on the operative day, was transfused
into the prime as required to increase the hematocrit value to at
least 25% in all groups during rewarming. Ventilation (100% oxy-
gen) was started 10 minutes before weaning from CPB. After 40
minutes of rewarming, animals were weaned from CPB and the
arterial and atrial cannulas were removed. Protamine (5 mg/kg)
was administered intravenously after the animals were in a hemo-
dynamically stable condition. The wound was closed in a sterile
fashion.
Postoperative Management
Animals remained sedated and paralyzed and were mechanically
ventilated and monitored continuously for 12 hours postoperatively,
at which time chest tubes were removed and animals were weaned
from ventilation and extubated. Neurologic and behavioral evalua-
tions were performed at 24-hour intervals beginning on postoperative
day (POD) 1. Neurologic scoring data were adapted from the neuro-
logic deficit score and overall performance category, as described
previously.10 On POD 4, the brain was fixed with 4 L of 4%
formaldehyde solution and the histologic assessment was done.
Data Collection
Body weight. Body weight was measured before the experi-
ment and on PODs 1 and 4.
Total body water estimation by bioelectrical impedance.
Percent change of total body water was measured at baseline and
Figure 2. Oxyhemoglobin (HbO2) decay curve and normalized HbO2 nadir time. During hypothermic circulatory
arrest (HCA), the curve linear decrease in HbO2 signal (HbO2 decay curve) can be described by a logarithmic
function, HbO2 = a log(t) + b, dHbO2/dt = a/t, where t is the time after the onset of HCA and a and b are constants.
We have defined that HbO2 signal reaches the plateau state (nadir value) when the slope of fitting curve, name-
ly the differential coefficient, dHbO2/dt, becomes more than –0.5. HbO2 nadir time was normalized by using the
temperature coefficient of 2.5 for the young piglet. Gp, Group.
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repeated at weaning from CPB, 1 hour and 3 hours after the pro-
cedure, and on POD 1.
Blood gas analyses. Arterial blood gas values, including elec-
trolyte, glucose, and lactate concentrations, were measured at
baseline, every 10 minutes during cooling and rewarming, and
after the procedure as needed (NOVA 900; Nova Biomedical,
Waltham, Mass).
NIRS. A pair of fiberoptic optodes was attached to the head
of the animal with a probe holder after induction of anesthesia.
The spacing of optodes was 4.0 cm in a coronal plane. These 2
optodes, a transmitter and a receiver of laser light of near-
infrared wavelength, were connected to NIRS (NIRO-300;
Hamamatsu Photonics K.K., Hamamatsu City, Japan). This
device calculated the relative concentration changes in oxy-
genated hemoglobin (HbO2), deoxygenated hemoglobin, oxi-
dized cytochrome a,a3, and tissue oxygenation index, which
shows the ratio of tissue oxygenation and total hemoglobin. Data
were recorded every 10 seconds after the induction of anesthesia
and for 3 hours after weaning from CPB.
Biochemical analyses. Blood samples were drawn before CPB
and on POD 1 to measure total protein, albumin, total bilirubin,
aspartate transaminase, alanine transaminase, lactate dehydroge-
nase, creatinine kinase, alkaline phosphatase, blood urea nitrogen,
and creatinine. Concentration of the brain ischemic marker S-100
protein was assessed at baseline, 30 minutes and 2 hours after
weaning from CPB, and on POD 1. The blood samples were
immediately centrifuged, and the serum was stored at –70°C for
later measurement by a luminescence immunoassay (Sangtec LIA
100; AB Sangtec Medical, Bromma, Sweden).11
Neurologic and behavioral evaluations. Details have been
described elsewhere.10 Neurologic deficit score (500: brain death;
0: normal) and overall performance category (5: brain death; 1:
normal) were used for neurologic and behavioral evaluations and
were carried out by one veterinarian who was blinded to the exper-
imental protocol.
Histologic assessment. Details have been described else-
where.12 Histologic evaluation (5: necrosis; 0: normal) was per-
formed by a neuropathologist in a blinded fashion.
Statistical Analysis
All results were expressed as mean ± standard error of the mean
and analyzed by a statistical analysis software package
(StatView 4.5; SAS Institute, Inc, Cary, NC).  Analysis of vari-
ance and the Bonferroni test were used to analyze the data
between the groups. Nonparametric correlation coefficients
according to Spearman were used for the correlation analyses of
the NIRS data with the neurologic deficit score, overall perfor-
mance category, and histologic score. 
Results
Experimental Conditions
The experimental conditions for each group are shown in
Tables 1 and 2. There were no significant differences
between the groups in body weight and esophageal tem-
perature before the operation and in pH, PaO2, and PaCO2
during the experiments. On the other hand, there was a
Cardiopulmonary Support and Physiology Sakamoto et al
Figure 3. Results of neurologic and behavioral evaluations. NDS, Neurologic deficit score; OPC, overall perfor-
mance category; POD, postoperative day; Gp, group.
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difference in mixed venous oxygen saturation (SvO2) dur-
ing the cooling phase (P < .0001). During the cooling
phase, hematocrit value and temperature were set accord-
ing to protocol, but no differences were noted between the
groups after rewarming and on POD 1. Mean arterial pres-
sure was significantly higher in group 3 (30%/25°C) dur-
ing the cooling phase (P <.0001), but no significant dif-
ferences existed between the groups after rewarming and
on POD 1. Also, osmolarity was significantly higher in
groups 1 (30%/15°C) and 3 (30%/25°C) during the cool-
ing phase (P = .0003).
Operative Results
Two animals died; one had ventricular fibrillation 9 hours
after weaning from CPB and the other had a severe tension
pneumothorax on POD 1. All data from these animals were
excluded from analysis. Two animals (hematocrit values of
30% and 20%, temperatures of 15°C and 25°C, and HCA
durations of 100 minutes each), in which extremely low
cerebral oxygenation was detected by NIRS, died of severe
brain damage with seizures at 5 to 6 hours after extubation
on POD 1. Another animal (20%, 25°C, 80 minutes) died of
brain herniation, which was confirmed by brain fixation
immediately after death on POD 4. Data from these animals
were included in the analysis, although histologic informa-
tion was not obtained in 2 of them.
Body Weight Change
The changes in percentage body weight were significantly dif-
ferent between the groups on POD 1. The groups assigned to
higher hematocrit values gained less weight. However, body
weights of almost all animals returned to the preoperative level
and there were no significant differences on POD 4 (Table 1).
Total Body Water Content
Calculated percentage of total body water content showed
marked edema in groups 2 (20%/15°C) and 4 (20%/25°C)
after weaning from CPB (Table 2).
NIRS (Figures 1 and 2)
The HbO2 signal increased significantly during the cooling
phase in all groups. In groups 1 (30%/15°C) and 3
(30%/25°C), the HbO2 signal continued to increase during
the entire cooling phase, whereas the HbO2 signal reached a
plateau after about 20 minutes in groups 2 (20%/15°C) and 4
(20%/25°C). Total hemoglobin showed almost the same pat-
tern as HbO2 during the cooling phase. On the other hand, tis-
sue oxygenation index demonstrated an increase without
plateau in all groups, and there was significant difference
between groups 1 (30%/15°C) and 4 (20%/25°C) at the end
of cooling. From the onset of HCA, there was a decline in
HbO2, oxidized cytochrome a,a3, and tissue oxygenation
index and a reciprocal increase in deoxygenated hemoglobin.
Figure 4. Results of histologic scores. HCA, Hypothermic circulatory arrest.
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In groups 2 (20%/15°C) and 4 (20%/25°C), HbO2 declined to
a plateau within approximately 30 minutes, whereas in
groups 1 (30%/15°C) and 3 (30%/25°C), the plateau occurred
after approximately 60 and 40 minutes, respectively. During
HCA, the decrease in HbO2 signal (HbO2 decay curve) can be
described by a logarithmic function,
HbO2 = a log(t) + b, dHbO2/dt = a/t 
where t is the time after the onset of HCA and a and b are
constants. We have defined that HbO2 signal reaches the
plateau state (nadir value) when the slope of the fitting curve,
namely the differential coefficient (dHbO2/dt), becomes
more than –0.5. Time to reach plateau was calculated in each
case. In groups 2 (20%/15°C) and 4 (20%/25°C), this was
28.7 ± 2.4 minutes and 23.1 ± 1.7 minutes, whereas in
groups 1 (30%/15°C) and 3 (30%/25°C), this time was 51.3
± 4.1 minutes and 41.4 ± 2.9 minutes. Analysis of variance
revealed a highly significant effect of hematocrit value (P <
.001) and temperature (P < .01). Bonferroni t test indicated
that group 1 (30%/15°C) is longer than group 2 (20%/15°C)
and group 4 (20%/25°C) (P < .001 for each), and group 3
(30%/25°C) is longer than group 2 (20%/15°C) (P = .02) and
group 4 (20%/25°C) (P < .001). No differences were detect-
ed between group 1 (30%/15°C) and group 3 (30%/25°C) (P
= .13) or between group 2 (20%/15°C) and group 4
(20%/25°C) (P = .98). The duration from reaching nadir
until reperfusion was calculated in each case and was termed
“HbO2 nadir time.”
Enzymes
No significant difference existed between the groups. The
increase of aspartate transaminase and alkaline transami-
nase levels tended to be larger when the hematocrit value
was lower and the HCA was longer. However, ischemic
damage to the whole body as determined by enzyme
changes was considered mild on the whole. The S-100 pro-
tein peaked at 30 minutes after CPB and decreased to nor-
mal on POD 1. However, there were no differences between
the groups (data not shown).
Neurologic and Behavioral Evaluations (Figure 3)
The neurologic deficit score and overall performance cate-
gory showed relatively rapid recovery in all groups. Most
animals assigned to 15°C recovered and showed normal
performance without neurologic deficit by PODs 3 and 4.
However, the animals assigned to 25°C with longer dura-
tions of HCA did not recover to normal.
Histological Assessment (Figure 4)
Neuropathologic injury was evaluated in the same man-
ner as in previous studies.12 Evidence of hypoxic-
ischemic injury was indicated by the presence of hypere-
osinophilic shrunken neurons with karyorrhectic nuclei.
Damage scores for all regions were summed and shown
as total score. Histologic damage was found predomi-
nantly in the caudate nucleus. All 3 animals with the
higher hematocrit value (30%), the lower temperature
(15°C), and the shortest HCA (60 minutes) showed no
brain damage. On the other hand, all animals with the
lower hematocrit value (20%), the higher temperature
(25°C), and the longest HCA (100 minutes) demonstrat-
ed severe brain damage. There was a tendency for worse
score when hematocrit value was lower, temperature was
higher, and HCA was longer.
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TABLE III. Spearman’s correlation coefficients for NIRS data and neurologic and behavioral evaluations
NIRS data variable Aggregate function NDS 1 OPC 1 NDS 4 OPC 4
HbO2 (µmol/L · DPF) Maximum –0.315 –0.373* –0.197 –0.178
Minimum –0.469† –0.470† –0.537† –0.545†
HHb (µmol/L · DPF) Maximum –0.174 –0.225 –0.041 –0.044
Minimum –0.047 –0.068 0.132 0.177
HbT (µmol/L · DPF) Maximum –0.271 –0.333 –0.104 –0.090
Minimum –0.281 –0.313 –0.239 –0.243
CytO2 (µmol/L · DPF) Maximum –0.058 –0.187 0.052 0.052
Minimum 0.001 –0.118 0.016 0.027
TOI (%) Maximum –0.364* –0.377* 0.033 0.064
Minimum –0.044 0.061 –0.037 –0.015
HCA 5 min –0.480† –0.452† –0.504† –0.504†
Normalized HbO2 nadir time (min) 0.717‡ 0.642‡ 0.716‡ 0.702‡
NDS 1(4), Neurologic deficit score at 1(4) day(s) postoperatively; OPC 1(4), overall performance category at 1(4) day(s) postoperatively; HbO2 , oxygenated
hemoglobin; DPF, differential path-length factor; HHb, deoxygenated hemoglobin; HbT, total hemoglobin; CytO2 , oxidized cytochrome a,a3; TOI, tissue oxy-
genation index.
*P < .05.
†P < .01.
‡P < .0001
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Correlation Between NIRS Data and Neurologic
Outcome (Tables 3 and 4 and Figures 5 and 6)
To establish a useful monitoring system, we evaluated
which NIRS data predicted the neurologic outcomes
shown by neurologic deficit score, overall performance
category, and histologic score. Because the metabolic rate
is different between the different temperatures, we nor-
malized the HbO2 nadir time by using an estimated tem-
perature coefficient of 2.5 for the young piglet.12
Normalized HbO2 nadir time was calculated as shown in
Figure 2. Minimal HbO2, tissue oxygenation index at 5
minutes after the beginning of HCA, and normalized
HbO2 nadir time were indices that were found to predict
neurologic outcome. In particular, normalized HbO2 nadir
time was significantly related to histologic score (rs =
0.826), neurologic deficit score (rs = 0.717 on POD 1,
0.716 on POD 4), and overall performance category (rs =
0.642 on POD 1, 0.702 on POD 4) (P <.001). All animals
in which HbO2 nadir time was less than 25 minutes were
free of behavioral or histologic evidence of brain injuries,
which were shown as neurologic deficit score more than 0
on POD 4, overall performance category more than 1 on
POD 4, and histologic score more than 0.
Discussion
This study has demonstrated that increasing duration of
HCA is associated with worse neurologic and histologic
outcome in the young piglet. Furthermore, the degree of
injury is exacerbated by use of a lower perfusate hematocrit
value (20% vs 30%) and/or a higher temperature (25°C vs
15°C). There is ongoing oxygen extraction during the early
phase of HCA that can be monitored by NIRS. A longer
duration of minimal or absent oxygen extraction (HbO2
nadir time) predicts worse neurologic and histologic out-
come. This NIRS-derived parameter could be useful as a
monitoring method to determine safe duration of HCA irre-
spective of the perfusion methods used to achieve HCA.
This study builds on two previous studies from our labora-
tory in which we examined the influence of hematocrit value
on outcome after deep HCA.9,14 In the first study, we mea-
sured cerebral high-energy phosphates with magnetic reso-
nance spectroscopy. We found that use of a low hematocrit
value (10%) was associated with a marked decline in cerebral
phosphocreatinine during cooling before deep HCA and
delayed recovery of adenosine triphosphate and creatine phos-
phate after deep HCA relative to a hematocrit value of 20% or
30%. In the second study, we independently manipulated
hematocrit value and oncotic pressure. These two studies used
a model with daily neurologic observations by a blinded vet-
erinarian as well as histologic assessment by a blinded neu-
ropathologist. Also, NIRS monitoring was undertaken simul-
taneously as well as magnetic resonance spectroscopy.
However, these studies used only one duration of HCA, that is,
60 minutes of deep hypothermia at 15°C, and this resulted in
Figure 5. Correlation figures between near-infrared spectroscopy (NIRS) data (normalized HbO2 nadir time) and
neurologic behavioral evaluations. NDS, Neurologic deficit score; OPC, overall performance category; POD,
postoperative day.
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relatively minor damage as noted by the normal neurologic
examinations 4 days postoperatively as well as fairly minor
histologic changes. Nevertheless, these two studies did con-
firm that a hematocrit value of 30% resulted in a better out-
come than a hematocrit value of 20%.14
In the present study, three different durations of HCA
and two different temperatures were used. As might seem
intuitively obvious and as previously reported by oth-
ers,13,15-19 a longer duration of HCA was associated with a
higher probability of neurologic and histologic injury.
However, it is clear that the amount of injury was also
strongly influenced by the conditions of HCA, specifically
the hematocrit value of the perfusate and temperature
(Figures 3 and 4). Analysis of the NIRS data provides a
compelling rationale for the role of hematocrit value and
temperature in influencing outcome. 
Figure 1 illustrates the changes in oxygenated and
deoxygenated hemoglobin during HCA. It can be seen that
with a hematocrit value of 30% there is a state of hyper-
oxygenation during cooling before HCA. Presumably this
represents not only the hyperoxygenated state of the arteri-
al perfusate (inspired oxygen fraction in the oxygenator
was 1.0) but also the fall in cerebral metabolic rate as brain
temperature decreases (70% of the NIRS hemoglobin sig-
nal is derived from cerebral venous blood). There is signif-
icantly less hyperoxygenation with a hematocrit value of
20% versus 30% during the cooling phase. After the onset
of HCA there is an immediate and ongoing fall in HbO2
and a rise in deoxygenated hemoglobin in all groups.
Furthermore, there are important differences in the shape of
these 4 curves, which are influenced by both hematocrit
and temperature. During the early period of HCA, groups 3
(30%/25°C) and 4 (20%/25°C), with higher temperature,
showed a more rapid decrease in HbO2 and increase in
deoxygenated hemoglobin than groups 1 (30%/15°C) and 2
(20%/15°C), suggesting inadequate metabolic suppression.
Groups 2 (20%/15°C) and 4 (20%/25°C), with lower hema-
tocrit value, reached a point of inflection after 28.7 ± 2.4
and 23.1 ± 1.7 minutes, respectively, beyond which point
there was minimal further decline in intracranial oxygenat-
ed hemoglobin. Groups 1 (30%/15°C) and 3 (30%/25°C),
with higher hematocrit values, did not reach this point of
inflection until 51.3 ± 4.1 and 41.4 ± 2.9 minutes after the
onset of HCA. If one relates the duration of HCA beyond
this point of inflection (“HbO2 nadir time,” which should
be normalized to account for the difference of temperature
Cardiopulmonary Support and Physiology Sakamoto et al
Figure 6. Correlation figures between near infrared spectroscopy (NIRS) data (normalized HbO2 nadir time) and
histologic scores.
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and therefore different metabolic rate) to neurologic and
histologic outcome (Figures 5 and 6), it is clear that this
NIRS-derived parameter is a powerful predictor of neuro-
logic injury.
The mechanism by which HbO2 nadir time predicts out-
come is unknown. However, it would seem reasonable to spec-
ulate that the gradual fall in HbO2 during HCA reflects ongo-
ing oxygen metabolism in cerebral neurons and astroglia.
Many previous reports have confirmed that cerebral metabo-
lism is not abolished during HCA.13,19 Deep hypothermia
should be able to suppress but cannot stop brain metabolism.
The finding that HbO2 reaches a nadir value suggests that the
available cerebral HbO2 is depleted at this point.20 When all
oxygen has been extracted from both the arterial and venous
phases within the brain, anaerobic metabolism ensues. If suf-
ficiently prolonged, the resulting acidosis can result in neu-
ronal and endothelial injury. Therefore, HbO2 nadir time could
be considered to be a critical period when cerebral neurons
cannot use oxygen but cerebral metabolism is still ongoing.
Interestingly, Figure 1 suggests that during the reperfusion
phase there is significantly greater cerebral flow with a higher
hematocrit value regardless of the temperature during circula-
tory arrest. We have made similar direct observations in the
cerebral microcirculation using the technique of intravital
microscopy (unpublished data).
In our previous reports in which we used NIRS, we focused
considerable attention on the potential value of the
cytochrome signal.21 Binding of oxygen to hemoglobin is
markedly altered under the conditions of bypass used before
circulatory arrest and complicates the interpretation of the
hemoglobin oxygenation status (in the same way that SvO2
data can be misleading during bypass with hypothermia and
alkalosis when there is a marked shift to the left of the oxyhe-
moglobin dissociation curve). However, recent studies from our
laboratory using sodium cyanide to dissociate cytochrome from
hemoglobin have failed to validate the cytochrome signal and in
fact have demonstrated a marked degree of crosstalk between
hematocrit and cytochrome.8a Efforts are presently underway to
derive an algorithm that will correct the cytochrome signal for
variations in hematocrit such as occur under the changing con-
ditions of CPB. On the other hand, the NIRO-300 device calcu-
lates tissue oxygenation index that is influenced by tissue satu-
ration as well as the hematocrit changes.22 In the current study,
tissue oxygenation index was 32% to 53% before CPB (base-
line), whereas SvO2 was usually 70% to 80% and sagittal sinus
saturation was 40%.4 Tissue oxygenation index increased up to
approximately 70% in all groups during the cooling phase
except in 2 nonsurviving animals that showed inadequate
increases of tissue oxygenation index, suggesting poor brain
oxygenation irrespective of hypothermia or hemodilution.
Tissue oxygenation index may therefore reflect brain oxygena-
tion state accurately even under conditions of deep hypother-
mia, hemodilution, and pH shifts. 
We have previously reported both laboratory and clinical
studies that suggest that the pH-stat strategy is preferable to the
alpha-stat strategy.23-26 Therefore, we used the pH-stat strategy
for all groups in this study. The pH-stat strategy (addition of
carbon dioxide to the oxygenator gas mixture) increases cere-
bral blood flow, thereby improving cooling of the brain and
increasing oxygen delivery before HCA. The oxyhemoglobin
dissociation curve is shifted to the right, improving oxygen
delivery, and cerebral metabolic rate is depressed during HCA,
thereby reducing oxygen requirements. Nevertheless, the alter-
native, alpha-stat strategy, continues to be widely applied. Its
TABLE IV. Spearman’s correlation coefficients for NIRS data and histologic score
Aggregate Dentate Caudate Total
NIRS data variable function Neocortex gyrus Hippocampus nucleus score
HbO2 (µmol/L · DPF) Maximum –0.376 –0.264 –0.167 –0.270 –0.254
Minimum –0.420* –0.485† –0.319 –0.430* –0.484†
HHb (µmol/L · DPF) Maximum –0.200 –0.081 –0.121 –0.179 –0.101
Minimum 0.023 0.091 0.066 –0.153 0.017
HbT (µmol/L · DPF) Maximum –0.217 –0.164 –0.122 –0.269 –0.205
Minimum –0.319 –0.254 –0.177 –0.266 –0.227
CytO2 (µmol/L · DPF) Maximum –0.071 0.022 –0.032 –0.159 –0.065
Minimum –0.157 –0.002 0.036 –0.123 –0.059
TOI (%) Maximum –0.149 –0.053 –0.164 –0.210 –0.203
Minimum 0.022 –0.023 0.099 –0.124 –0.182
HCA 5 min –0.590† –0.421* –0.248 –0.541† –0.594†
Normalized HbO2 nadir time (min) 0.673‡ 0.701‡ 0.473
† 0.716‡ 0.826‡
NIRS, Near infrared spectroscopy; HbO2 , oxygenated hemoglobin; DPF, differential path-length factor; HHb, deoxygenated hemoglobin; HbT, total hemoglo-
bin; CytO2 , oxidized cytochrome a,a3; TOI, tissue oxygenation index.
*P < .05.
†P < .01.
‡P < .0001.
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widespread use limits the relevance of the findings of our study
for many centers continuing to use the alpha-stat strategy.
Therefore, in future studies we plan to examine the influence of
hematocrit value in the setting of the alpha-stat strategy, partic-
ularly under HCA. We believe there will be an additive interac-
tion such that a combination of alpha-stat and lower hematocrit
value will be a particularly damaging combination and will
shorten the time to HbO2 nadir. We are hopeful that these fur-
ther studies will further validate the HbO2 nadir time as a use-
ful predictor of safe duration of HCA. In addition, we plan to
undertake further studies using continuous CPB in which we
will explore whether this parameter might also be useful in
defining safe levels of hemodilution and safe low flow states
such as are very widely applied in surgery for correction of
congenital heart anomalies.
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